Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Evaluating a new dropless approach for postoperative care after cataract surgery

Official title: Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population

Run by University of California, San Francisco · NCT05157113 · Data updated 2026-11-12

This study is testing a new way to care for patients after cataract surgery by using just one injection instead of multiple eye drops to see if it helps them recover better and stick to their treatment.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedMay 31, 2022
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedOctober 27, 2026
Trial IDNCT05157113 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 18 and older who are undergoing cataract surgery in both eyes and have been approved by an ophthalmologist.

Probably not a fit

Patients who require same-day bilateral cataract surgery or have a history of certain ocular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to simplify postoperative care for cataract surgery patients at Zuckerberg San Francisco General Hospital by replacing the traditional regimen of multiple eye drops with a single administration of an intraocular antibiotic and a subconjunctival steroid at the time of surgery. The focus is on a vulnerable population that often struggles with adherence to complex medication regimens, leading to higher rates of complications. By collecting preliminary data on postoperative outcomes, patient compliance, and satisfaction, the study seeks to assess the feasibility and effectiveness of this innovative approach in improving patient care. The study is interventional and is classified as Phase 4.

Why it matters

Potential benefit: If successful, this approach could significantly improve patient adherence to postoperative care and reduce complications after cataract surgery.

How similar studies have gone: While this approach is innovative for this specific population, similar studies have shown that simplifying postoperative regimens can lead to improved compliance and outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* ZSFG patient initially seen in the eye clinic, approved by attending ophthalmologist for cataract surgery in both eyes due to visually significant cataracts, and who elects to have cataract surgery in both eyes.
* Patients 18 years of age or older

Exclusion criteria:

* Patients requiring bilateral simultaneous (same-day bilateral) cataract surgery
* Patients with prior history of: endophthalmitis, advanced glaucoma, known history of intraocular pressure elevation due to steroids, prior intraocular surgery, cystoid macular edema/diabetic macular edema/retinal edema noted in the past 12 months prior to cataract surgery
* Patients with documented penicillin or cephalosporin allergy or intolerance
* Patients requiring combined same day cataract and ophthalmic subspecialty procedure (eg; combined cataract and glaucoma, retina, or cornea surgery).
* Patients who are pregnant or breastfeeding

Where it's running

  • Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG)
    San Francisco, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.